Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 82 of 574 for:    Genetic AND SNP

Diet Quality and Genetic Association With Body Mass Index: Results From Three Observational Studies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03577639
Recruitment Status : Active, not recruiting
First Posted : July 4, 2018
Last Update Posted : July 4, 2018
Sponsor:
Information provided by (Responsible Party):
Ming Ding, Harvard School of Public Health

Brief Summary:

Background In the most recent genome-wide association study (GWAS), of the 97 body mass index (BMI)-associated single nucleotide polymorphisms (SNPs) identified, more than half of the SNPs were highly enriched for expression in the central nervous system (CNS), which is the key site of central appetite regulation 1. Significant interaction between consumption of sugar-sweetened beverages and genetic score in relation to BMI has been found 2. However, it is not known whether diet quality could modify the genetic association with BMI. Moreover, identification of subgroup of established SNPs whose association with BMI could be most significantly modified by diet will provide evidence to individualized obesity prevention.

Hypotheses

  • SNPs enriched in the CNS (CNS SNPs) were more likely to be associated with food and nutrient intakes featured in alternative healthy eating index (AHEI) in comparison to SNPs enriched in other tissues (non-CNS SNPs).
  • Higher diet quality was related with less pronounced association between genetic score and BMI, particularly the score of CNS SNPs.

Study Population

  • 5,730 women in the Nurses Health Study (NHS) and 3,434 men in the Health Professional Follow-up Study (HPFS) who were sampled as controls
  • 21,740 women in the Women's Genome Health Study (WGHS) Exposure
  • Dietary quality will be measured by AHEI-2010, alternate Mediterranean diet (AMED), and the Dietary Approaches to Stop Hypertension (DASH) diet scores. Diet was measured repeatedly in the NHS (1984, 1986, 1990, 1994) and the HPFS (1986, 1990, 1994), and was measured at baseline in the WGHS.
  • Based on the most recent GWAS 1, we will classify the 97 BMI-associated SNPs into CNS SNP (54 SNPs) and non-CNS SNP (43 SNPs). Total, CNS, and non-CNS SNP scores will be calculated.

Outcome BMI measured after diet assessment with 2-year lag in the NHS and the HPFS and 3-year lag in the WGHS Statistical analysis

  1. The associations of individual SNP with AHEI components at baseline will be examined using linear regression and the results will be presented in Heatmap.
  2. The interactions between diet quality scores and genetic scores in relation to BMI will be examined using generalized linear model in the NHS and the HPFS and using linear regression in the WGHS. The genetic scores will include total SNP score, CNS SNP score, and non-CNS SNP score.
  3. Two-way stratification analysis will be conducted: the association of diet quality score with BMI will be stratified by genetic score; the association of genetic score with BMI will be stratified by diet quality score.
  4. The interactions between AHEI components and genetic scores in relation to BMI will be examined using generalized linear model in the NHS and the HPFS and using linear regression in the WGHS.

Condition or disease
Gene and Diet Interaction

Layout table for study information
Study Type : Observational
Estimated Enrollment : 11700 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diet Quality and Genetic Association With Body Mass Index: Results From Three Observational Studies
Actual Study Start Date : January 1, 1976
Estimated Primary Completion Date : December 12, 2030
Estimated Study Completion Date : December 12, 2030



Primary Outcome Measures :
  1. Body mass index [ Time Frame: 1984-2010 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
  • 5,730 women in the NHS and 3,434 men in the HPFS who were sampled as controls
  • 21,740 women in the WHGS
Criteria

Inclusion Criteria:

  • Participants with genetic data

Exclusion Criteria:

  • Participants with a history of diabetes, cardiovascular disease, and cancer
  Study Documents (Full-Text)

Documents provided by Ming Ding, Harvard School of Public Health:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Ming Ding, Research fellow, Harvard School of Public Health
ClinicalTrials.gov Identifier: NCT03577639     History of Changes
Other Study ID Numbers: 384957
First Posted: July 4, 2018    Key Record Dates
Last Update Posted: July 4, 2018
Last Verified: June 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No